Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical Development

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The early assessment of new drugs for Alzheimer\'s disease remains difficult because of the lack of predictive end-point. The use of a battery including different parameters could improve this early development of new drugs. Nevertheless, the interest of such a battery should previously be validated with the yet marketed AD drugs
Epistemonikos ID: 6b75860b8323762c346ff0f5b6cfaf4dd51c3a59
First added on: May 10, 2024